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A B S T R A C T
Immunologicmemory is a critical feature of the adaptive immune system to ﬁght recurrent infections. However,
themechanisms that shape the composition and function of thehumanmemory T-cell pool remain incompletely
understood.We here demonstrate that post-thymic human T-cell differentiationwas associatedwith the down-
regulation, but not loss, of the inhibitorymolecule CD5. The sensitivity of human CD8 and CD4memory T cells
to interleukin (IL)–15was inversely associatedwith the level of CD5 expression. CD5 expressionwas downregu-
lated by IL-15–mediated signaling in vitro and CD5lomemory T cells accumulated in the bonemarrow. Persistent
antigenic stimulation, as in the case of cytomegalovirus infection and rheumatoid arthritis (RA), was also associ-
ated with an increased number of CD5lo memory T cells. In conclusion, CD5 may be a useful marker to identify
memory T-cell subsets with distinct responsiveness to the homeostatic cytokine IL-15.
 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
Open access under CC BY-NC-ND license.1. Introduction
The ability to develop andmaintain highly functionalmemory T
cells after infection or immunization is a hallmark of the adaptive
immune response. However, the human memory T-cell pool is
heterogeneous, and comprises distinct populations that can be
distinguished based on homing markers and effector functions [1].
Cytokines have been shown to be essential for the long-termmain-
tenance of functional CD8 and CD4 memory T cells [2,3]. Yet,
cytokine-induced signaling can modulate phenotypic and func-
tional characteristics of memory T cells [4–7]. In addition, chronic
viral infections and autoimmune diseases have been shown to
induce distinct phenotypic and functional changes within the
memory T-cell pool [8,9]. Thus, antigens and cytokines dynamically
shape the memory T-cell pool throughout life [10].
So far, the role of the transmembrane glycoprotein CD5 in the
process of memory T-cell differentiation and maintenance has not
been addressed. CD5 surface expression is tightly regulated during
T-cell development, with low levels expressed on immature, double
negativeCD4–CD8– thymocytes, followedbyanapproximately sixfold
ncrease in CD5 at the double positive CD4CD8 stage and a further
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doi:10.1016/j.humimm.2011.03.028three- toﬁvefold increase inCD5expressiononmature, singlepositive
CD4 and CD8 thymocytes [11]. All mature T lymphocytes and a
subset of B cells, B-1a cells, express CD5 [11,12]. Data from CD5–/–
mice indicate that CD5 acts as a negative regulator of cellular activa-
tion by being recruited into lipid rafts and dephosphorylating signal-
ing molecules [13–16]. Recently, it has been demonstrated in mice
that the level of CD5 on naive T cells does not correlate only with the
strength of TCR-mediated signaling but also with the strength of re-
sponsiveness to cytokines, such as interleukin (IL)–15 [17]. Further-
more, the levelof the inhibitorymoleculeCD5onnaiveTcells couldbe
downregulated by cytokines, such as IL-7 and IL-21, which rendered
the cytokine-primed naive T cells more responsive to antigenic stim-
ulation [18].
In this studywe demonstrate that the expression of the inhibitory
molecule CD5 is decreased during humanmemory T-cell differentia-
tion and is associated with the strength of responsiveness to IL-15. In
addition, we show which environmental cues may be involved in
regulating CD5 expression on post-thymic humanmemory T cells.
2. Subjects and methods
2.1. Peripheral blood and bone marrow samples
Peripheral blood samples were obtained from healthy volun-
teers. All participants had given their informed written consent,
and the studywas approvedby the Ethics Committee of theMedical
blished by Elsevier Inc. Open access under CC BY-NC-ND license.
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D. Herndler-Brandstetter et al. / Human Immunology 72 (2011) 627-631628University Innsbruck. Cytomegalovirus (CMV) seropositivity was
determined by enzyme-linked immunosorbent assay (ELISA) using
ENZYGNOST (Dade Behring, Vienna, Austria). Peripheral blood
mononuclear cells (PBMC)were isolated by Ficoll-Hypaque density
gradient centrifugation (Amersham Biosciences).
Paired blood and bone marrow (BM) samples were obtained
from individuals who had given informed written consent and the
study was approved by the Ethics Committee of the Medical Uni-
versity Innsbruck. Bone from the iliac crest, which otherwisewould
have been discarded based on necessary bone molding/recontour-
ing before insertion into other areas of the body, in particular facial
regions was harvested at the Department of Cranio-Maxillofacial
and Oral Surgery at the Medical University, Innsbruck. Exclusively
bone biopsies from systemically healthy individuals who did not
receive immunomodulatory drugs or who had diseases known to
inﬂuence the immune system, including autoimmune diseases and
cancer, were used. The bone biopsy samples were washed with
complete MEM (Invitrogen, Lofer, Austria), fragmented, and
treated with highly puriﬁed collagenase (Worthington, Lakewood,
NJ; 20 U/ml) for 1 h at 37C. Thereafter, collagenase-treated cells
were centrifuged and BMmononuclear cells (BMMC)were puriﬁed
by density gradient centrifugation (Ficoll-Hypaque; Amersham
Biosciences, Vienna, Austria).
Peripheral blood samples were obtained from 10 individuals
who fulﬁlled the American College of Rheumatology (ACR) classiﬁ-
cation criteria for RA [19]. Median disease duration was 18 years
(range 5–25 years), and 80% of the patients were positive for rheu-
matoid factor. The RA patients had moderate clinical disease activ-
ity (median disease activity score (DAS)-28 4.3; range 1.7–6.6) and
were treated with methotrexate (n  5), other conventional dis-
ease-modifying antirheumatic drugs (DMARDs) (n  3), or tumor
necrosis factor (TNF)– blocking agents (n  2). The study was
approved by the Ethics Committee of the Medical University Graz.
Fig. 1. CD5 is downregulated during peripheral human CD8 and CD4 memory T
-cell subsets. Memory subsets were classiﬁed as central-memory (TCM; CD45RA
–C
D45RACCR7–). Numbers indicate CD5 mean ﬂuorescence intensity (MFI). Data ar
-cell subsets (n 12). Statistical analysis was performed using Student’s t test. ***p
of CD5 on human CD4memory T-cell subsets. Memory subsets were classiﬁed as d
Bar graph shows CD5MFI on human CD4 memory T-cell subsets (n 8). Statistical analy
CM vs TEMRA.2.2. Flow cytometry and cell culture experiments
Immunoﬂuorescence surface staining was performed by adding a
panel of directly conjugated mAbs to freshly prepared PBMC and
BMMC. The antibodies used were CD3 (PE-Cy7 and APC-Cy7), CD4
(PerCP), CD5 (PE and APC), CD28 (APC), CD45RA (APC), CD62L (APC-
Cy7), CD69 (PE), CD122 (PE), CD132 (PE), and TCR (PE) (all BD
Pharmingen, San Diego, CA), CD8 (PerCP) (BioLegend, San Diego, CA),
and CCR7 (FITC) (R&D Systems, Minneapolis, MN). The labeled cells
weremeasuredby a FACSCanto II (BDBiosciences, SanDiego, CA), and
the datawere analyzed using FACSDiva software (BDBiosciences, San
Diego, CA).
Cell culture experiments were performed with RPMI 1640 (Invit-
rogen, Lofer, Austria) supplemented with 10% FCS (Sigma-Aldrich,
Vienna, Austria) and1%kanamycin sulfate (Invitrogen, Lofer, Austria).
To analyze the responsiveness of memory T-cell subsets to IL-15,
peripheral bloodT cellswere stimulatedwith IL-15 (50ng/ml; Sigma-
Aldrich, Vienna, Austria) for 4 days and CD69wasmeasured on CD8
and CD4 memory T-cell subsets. The gating of memory T cells was
performedbyexcludingCCR7CD45RAnaiveTcells. Lowexpression
f CD5 was deﬁned by gating on the lower third of CD5-expressing T
ells and the gating was conﬁrmed by additional CD45RA and CD28
taining. Thus, CD5lo T cells had a CD45RA/–CD28– phenotype. To
determine the regulation of CD5 expression, peripheral blood CD8
and CD4 T cells were labeled with the ﬂuorescent dye carboxyﬂuo-
escein diacetate succinimidyl ester (CFSE) as described previously
20] and stimulatedwith IL-15, 50 ng/ml for 7 days in the presence of
rradiated autologous PBMC.
.3. Statistical analysis
Differences between groups were evaluated using two-tailed
tudent’s t test. A value of p  0.05 was considered statistically
signiﬁcant.
ifferentiation. (A) Density plots show expression of CD5 on human CD8 memory
), effector-memory (TEM; CD45RA
–CCR7–), and effector-memory CD45RA (TEMRA;
esentative of 12 experiments. Bar graph shows CD5 MFI on human CD8memory
01, TCM vs TEM and
###p 0.001 TCM vs TEMRA. (B) Density plots show the expression
ed above. Numbers indicate CD5MFI. Data are representative of eight experiments.
###-cell d
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3.1. CD5 is downregulated during post-thymic CD8+ and CD4+
memory T-cell differentiation in human beings
By using ﬂow-cytometric analysis, we could demonstrate that
CD5 was highly expressed on central-memory CD8 T cells,
hereas its expression was downregulated in CD45RA–CCR7–
and CD45RACCR7– effector-memory CD8 T cells (Fig. 1A). Sim-
larly, when using CD45RA and CD28 to characterize memory
-cell subsets, CD45RACD28– effector-memory T cells dis-
layed the lowest level of CD5 expression (Figs. S1A and S1B).
owever, the expression of CD3 and TCRwere not downregu-
lated during CD8 memory T-cell differentiation (Fig. S1A). In
CD4 T cells, the expression of CD5 was also downregulated
during post-thymic memory T-cell differentiation (Fig. 1B and
Figs. S1C and S1D), whereas the expression of CD3 and TCR
was not (Fig. S1C). These results indicate that the expression of
CD5 is not only regulated during thymic development [11], but
highlight a role for CD5 during post-thymic CD8 and CD4
memory T-cell differentiation in human beings.
3.2. Expression level of CD5 on human CD8+ and CD4+ memory T
ells is inversely associated with the strength of responsiveness to
L-15
CD5 has been shown to act as a negative regulator of cellular
Fig. 2. Responsiveness of human CD8 and CD4memory T-cell subsets with disti
ctivation molecule CD69 upon IL-15–mediated stimulation of CD8memory T cell
cells with high (ﬁlled bars), intermediate (gray bars), and low (open bars) expre
erformed using paired Student’s t test (n 11). (B) Representative density plots tha
ith distinct CD5 level. Bar graph shows percentage of CD69-expressing CD4 me
ars), and low (CCR7–CD45RA; open bars) expression of CD5 after stimulationwith
(n 11). ***p 0.001, CD5hi vs CD5int; ###p 0.001, CD5hi vs CD5lo andp 0
memory T cells with high (ﬁlled bars), intermediate (gray bars), and low (open bars)
CD4memory T cells with high (ﬁlled bars), intermediate (gray bars) and low (open
*p  0.05, CD5hi vs CD5int; #p  0.05, CD5hi vs CD5lo and p  0.05, CD5int vs CD5loctivation by dephosphorylating signaling molecules [13,15,16] snd to modulate cytokine responsiveness of naive CD8 T cells
[17]. We thus analyzed whether memory T cells with distinct
CD5 levels differ in their responsiveness to IL-15, which is known
to be an important cytokine for memory T-cell survival and
proliferative renewal [2,21]. Although memory T-cell subsets
did not express CD69 in the absence of IL-15 (data not shown),
IL-15 led to the upregulation of the activation molecule CD69 on
CD8 and CD4 memory T cells and was inversely associated
ith the level of CD5 (Figs. 2A, 2B). One explanation for the
yper-responsiveness of CD5lo CD8 and CD4memory T cells to
L-15 could be that these cells have a higher number of cytokine
eceptors. However, this is unlikely, because there were no
arked differences in the expression of the signaling chains
D122 (IL-2R) and CD132 (c) between memory T cells with
different levels of CD5 (Figs. 2C, 2D). Interestingly, a high expres-
sion of monosialotetrahexosylganglioside (GM) 1–containing
lipid rafts was associated with a high responsiveness to IL-2 and
IL-15 in naive CD8 T cells and was directly correlated with the
xpression of CD5 [17]. Accordingly, a recent study in human
ubjects demonstrated that central-memory CD4 T cells ex-
ressed a high membrane lipid order (GM1lo), whereas effector-
memory CD4 T cells expressed an intermediate membrane lipid
order (GM1int) [22]. This indicates that the GM1 content directly
orrelates with the responsiveness to IL-15 in memory T-cell
5 levels to IL-15. (A) Representative density plots that show the expression of the
distinct CD5 level. Bar graph shows percentage of CD69-expressing CD8memory
of CD5 after stimulation with IL-15, 50 ng/ml for 4 days. Statistical analysis was
the expression of CD69 upon IL-15–mediated stimulation of CD4memory T cells
T cells with high (CCR7CD45RA–; ﬁlled bars), intermediate (CCR7–CD45RA–; gray
, 50 ng/ml for 4 days. Statistical analysis was performed using paired Student’s t test
D5int vs CD5lo. (C) Flow-cytometric analysis of CD122 MFI and CD132 MFI in CD8
ssion of CD5 (n 8). (D) Flow-cytometric analysis of CD122MFI and CD132MFI in
expression of CD5 (n 8). Statistical analysis was performed using Student’s t test.nct CD
s with
ssion
t show
mory
IL-15
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expreubsets but inversely correlates with the level of CD5.
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memory T cells accumulate in the human BM
We next analyzed which factors may contribute to the down-
regulation of CD5 on human T cells. We therefore stimulated puri-
ﬁed, CFSE-labeled CD8 and CD4 T cells with IL-15 for 7 days.
lthough CD8 and CD4 T cells did not proliferate in the absence
of IL-15 (data not shown), CD5was progressively downregulated in
proliferating CD8 and CD4 T cells stimulatedwith IL-15 (Fig. 3A).
Comparison of CD5 levels between CD8 T cells that have not
proliferated (CFSEhi) and cells that have undergone four or more
cell divisions (CFSElo) demonstrated that IL-15–mediated signaling
ecreased the CD5 mean ﬂuorescence intensity (MFI) by 21% (Fig.
A). Similarly, CD5was downregulated in proliferating CD4 T cells
stimulated with IL-15 and IL-15–mediated signaling decreased the
CD5MFI by 36% (Fig. 3A). The BM has been shown to be a preferred
site for IL-15–mediated proliferation of memory T cells [23] and a
higher expression of IL-15 was identiﬁed in BMMC compared with
PBMC [24]. (Moreover, CD4 and CD8 T cells were in close contact
Fig. 3. Impact of environmental cues, persistent CMV infection, and RA on the fr
roliferation in CD8 and CD4 T cells. Histograms show expression of CD5 in CFSE-
f irradiated PBMC. One representative experiment is shown. Graphs show CD5 M
timulated with IL-15 for 7 days. Statistical analysis was performed using paired Stu
pool in PB and bone marrow (BM) of healthy individuals (deﬁnition and phenotyp
ercentage of CD5lo cells within the CD8 T-cell pool in CMV seronegative persons
Right bar graph shows percentage of CD5lo cells within the CD4 T-cell pool in CMV
n13; 415years). (D) Left bar graph showspercentage of CD5lo cellswithin the C
n 10; 71 3 years). Right bar graph shows percentage of CD5lo cells within the CD
(n  10; 71  3 years). Healthy persons and RA patients were all CMV seropositive.ith IL-15–producing cells in the human BM [24]. We therefore de-ermined the expression of CD5 onmemory T cells in the human BM.
ur results demonstrate that a higher number of CD5lo CD8 and
CD4memory T cells accumulated in the human BM compared with
eripheral blood (Fig. 3B). Thus, our results highlight a so far unappre-
iated role for IL-15–mediated signaling inmodulating the expression
f the inhibitorymolecule CD5, which is associatedwith the strength
f responsiveness to IL-15. Intriguingly, asmemoryT-cellhomeostasis
s critically dependent on IL-15–dependent signaling [2], increased
ensitivity of CD5lo memory T cells to IL-15may explain the selective
urvival and/or expansion of CD5lo memory T cells in the human BM.
3.4. Persistent CMV infection and RA drive the accumulation of CD5lo
memory T cells
We next examined whether persistent infection with CMV,
which is known to drive the accumulation of highly differentiated T
cells [25,26], may alter the frequency of CD5lo memory T cells in
human beings. Indeed, the number of CD5lo CD8 and CD4mem-
ory T cells was increased in CMV seropositive compared with CMV
cy of CD5lo T cells. (A) Regulation of CD5 surface expression by IL-15–mediated
d CD8 and CD4 T cells stimulated with IL-15, 50 ng/ml for 7 days in the presence
FSEhi (not divided) and CFSElo CD8 and CD4 T cells (four or more cell divisions)
s t test. (B) Graphs show percentage of CD5lo cells within the CD8 and CD4 T-cell
D5lo T cells is explained in Subjects and methods section). (C) Left bar graph shows
6; mean age SEM: 41 4 years) and seropositive persons (n 15; 41 5 years).
egative persons (n 23; mean age SEM: 38 4 years) and seropositive persons
-cell pool in healthy persons (n38;mean age SEM: 721years) andRApatients
cell pool in healthy persons (n 28;mean age SEM: 71 1 years) and RA patients
tical analysis was performed using Student’s t test.equen
labele
FI in C
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D. Herndler-Brandstetter et al. / Human Immunology 72 (2011) 627-631 631CD5lo CD4memory T cellswas identiﬁed in theperipheral bloodof
atients with RA compared with age- and CMV-matched healthy
ndividuals (Fig. 3D). Thus, our results indicate that persistent in-
ection with CMV and pro-inﬂammatory autoimmune diseases,
uch as RA, characteristically shape the functional composition of
he human memory T-cell pool by driving the accumulation of
D5lo memory T cells. The lower expression level of CD5 on these
highly differentiated memory T cells is also associated with an
increased responsiveness to the homeostatic cytokine IL-15, which
may represent a survival advantage andmay drive their accumula-
tion in the BM. In the case of RA, IL-15 is increased in the synovium
andBM [27,28] andmay decrease the activation threshold of highly
differentiated, IL-15–sensitive CD5lo memory T cells, thereby con-
tributing to increased T-cell activation and inﬂammation [28].
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